The largest database of trusted experimental protocols
> Procedures > Diagnostic Procedure > Cardiography, Impedance

Cardiography, Impedance

Cardiography, Impedance is a non-invasive technique used to measure changes in electrical impedance within the thoracic cavity, providing insights into cardiac function and hemodynamics.
This method involves applying a small, high-frequency alternating current to the body and measuring the resulting voltage changes, which are influenced by factors such as blood flow, fluid content, and tissue composition.
Impedance cardiography has been utilized in a variety of clinical and research settings, including the assessment of cardiac output, fluid status, and cardiovascular reactivity.
The PubCompare.ai platform can help streamline your impedance cardiography research by providing easy access to relevant protocols from the literature, preprints, and patents, and offering AI-powered comparisons to identify the best approaches and products for your needs.
This can help improve the efficiency and outcomes of your scientific investigations.

Most cited protocols related to «Cardiography, Impedance»

Under a Clinical Trial Agreement ANSAR supplied an ANX 3.0 device for clinical evaluation. ANSAR did not participate in any way in the design or conduct of the study or in the interpretation of the results. The testing procedure was conducted according to the company’s instructions and done by or under the supervision of personnel certified by ANSAR to carry out the testing protocol.
Electrocardiographic leads were attached and an automated arm blood pressure cuff applied. The electrocardiogram was used for power spectral analysis of heart rate variability and trans-thoracic electrical impedance for analysis of respiratory rate variability [6 (link)]. The ANX 3.0 gives instructions to subjects for the stages of the testing—baseline relaxed breathing for 5 minutes while sitting, deep breathing for 1 minute, return to baseline breathing for 1 minute, 5 Valsalva maneuvers, return to baseline for 2 minutes, and standing for 5 minutes.
A parameter termed RFa was calculated as the area within a 0.12 Hz bin of the spectrum centered at the fundamental respiratory frequency. The fundamental respiratory frequency, in breaths per second, is the frequency of the highest peak of the respiratory rate variability spectrum. In a healthy individual this frequency corresponds to the inverse of the respiratory rate during resting breathing. LFa was calculated from the LF component of the heart rate variability after taking into account RFa [6 (link)]. The exact calculations made by the ANSAR device were not available to us.
Based on the obtained LFa and RFa values the ANSAR device reports diagnostic implications and recommendations about possible treatments. “Sympathetic withdrawal” is reported if the standing:baseline ratio of LFa is less than 0.9. OH is diagnosed if a decrease of more than 20 mm Hg in systolic blood pressure or more than 10 mm Hg in diastolic pressure is found after 2 minutes of standing. If there is OH and the heart rate increases during standing, then the OH is reported as non-neurogenic; otherwise the OH is reported as neurogenic. A drop in blood pressure that is insufficient to satisfy criteria for OH is reported as “orthostatic intolerance.” If the blood pressure decreases by less than 5 mm Hg or the heart rate increases by less than 30 bpm, the diagnosis is possible “pre-clinical orthostatic intolerance.”
Publication 2010
Ansar Blood Pressure Cardiography, Impedance Diagnosis Electrocardiography Medical Devices Neurogenesis Pressure, Diastolic Rate, Heart Respiratory Rate Supervision Systolic Pressure Valsalva Maneuver
A whole-body impedance cardiography device (CircMonR, JR Medical Ltd, Tallinn, Estonia), which records the changes in body electrical impedance during cardiac cycles, was used to determine beat-to-beat HR, stroke index (stroke volume in proportion to body surface area, ml/m2), cardiac index (cardiac output/body surface area, l/min/m2), and PWV (m/s)
[29 (link)-31 (link)]. Left cardiac work index (kg*m/min/m2) was calculated by formula 0.0143*(MAP–PAOP)*cardiac index, which has been derived from the equation published by Gorlin et al.
[32 (link)]. MAP is mean radial arterial pressure measured by tonometric sensor, PAOP is pulmonary artery occlusion pressure which is assumed to be normal (default 6 mmHg), and 0.0143 is the factor for the conversion of pressure from mmHg to cmH2O, volume to density of blood (kg/L), and centimetre to metre. Systemic vascular resistance index (systemic vascular resistance/body surface area, dyn*s/cm5/m2) was calculated from the signal of the tonometric BP sensor and cardiac index measured by CircMonR.
To calculate the PWV, the CircMon software measures the time difference between the onset of the decrease in impedance in the whole-body impedance signal and the popliteal artery signal. From the time difference and the distance between the electrodes, PWV can be determined. As the whole-body impedance cardiography slightly overestimates PWV when compared with Doppler ultrasound method, a validated equation was utilized to calculate values that correspond to the ultrasound method (PWV = (PWVimpedance*0.696) + 0.864)
[30 (link)]. PWV was determined only in the supine position because of less accurate timing of left ventricular ejection during head-up tilt
[30 (link)]. A detailed description of the method and electrode configuration has been previously reported
[31 (link)]. PWV was also recorded after the head-up tilt in all subjects, and the average difference between the mean PWV before and after the head-up tilt was 0.024 ± 0.388 m/s (mean ± standard deviation), showing the good repeatability of the method (repeatability index R 98%, Bland-Altman repeatability index 0.8)
[33 ]. The cardiac output values measured with CircMonR are in good agreement with the values measured by the thermodilution method
[31 (link)], and the repeatability and reproducibility of the measurements (including PWV recordings) have been shown to be good
[34 (link),35 (link)].
Full text: Click here
Publication 2013
Blood Volume Body Surface Area Cardiac Output Cardiography, Impedance Cerebrovascular Accident Head Heart Human Body Left Ventricles Medical Devices Popliteal Artery Pressure Pulmonary Wedge Pressure Stroke Volume Thermodilution Tonometry Total Peripheral Resistance Ultrasonography Ultrasounds, Doppler
A whole-body impedance cardiography device (CircMonR, JR Medical Ltd, Tallinn, Estonia), which records the changes in body electrical impedance during cardiac cycles, was used to determine beat-to-beat HR, stroke volume, cardiac output, and aortic-popliteal PWV [27 (link)]. The mechanism of function, electrode placement, and processing of impedance cardiography data have been previously described [21 (link), 27 (link)–29 (link)]. Briefly, the impedance cardiography method calculates PWV between the level of the aortic root and the popliteal artery by the use of the whole-body impedance signal and the signal measured from the popliteal artery region [27 (link), 28 (link)]. The PWV results obtained using CircMonR show good repeatability [29 (link)], and normal values for PWV in 799 individuals (age 25–76 years) have been previously published [30 (link)]. We have also shown that the determination of stroke volume using impedance cardiography versus 3-dimensional echocardiography show good correlation [29 (link)]. SVR was calculated from the tonometric radial BP signal and cardiac output measured by the CircMonR device by subtracting average normal central venous pressure (4 mmHg) from mean arterial pressure and dividing it by cardiac output. Mean arterial pressure was calculated by using the formula: [(systolic BP)/3 + 2 × (diastolic BP)/3]. Cardiac output, stroke volume and SVR were indexed to body surface area (abbreviated as CI, SVI and SVRI, respectively).
Full text: Click here
Publication 2016
Aorta Aortic Root Body Surface Area Cardiac Output Cardiography, Impedance Echocardiography, Three-Dimensional Heart Human Body Medical Devices Popliteal Artery Pressure, Diastolic Stroke Volume Systolic Pressure Tonometry, Ocular Venous Pressure, Central
Hemodynamics recordings were carried out in a quiet, temperature-controlled laboratory by a research nurse. The subjects were instructed to refrain from caffeine-containing products, smoking, and heavy meals for at least 4 h, and from alcohol for at least 24 h prior to the investigation. Before the actual measurement the subjects were resting supine for approximately 10 min, during which period electrodes for impedance cardiography were placed on the body surface, a tonometric sensor for pulse wave analysis was fixed to the left wrist on the radial pulsation, and a brachial cuff for BP calibration was placed to the right upper arm. Then hemodynamic variables were continuously captured in a beat-to-beat fashion for 5 min in supine position and for 5 min during passive head-up tilt to 60 degrees. Mean values of each measured minute of the experiment were calculated and used in statistical analyses.
Full text: Click here
Publication 2013
Arm, Upper Caffeine Cardiography, Impedance Ethanol Head Hemodynamics Human Body Nurses Pulse Wave Analysis Tonometry Wrist
The following measures were collected during baseline and the TSST: electrocardiography (ECG, Biopac, Goleta, CA), impedance cardiography (NICO, Biopac, Goleta, CA), and blood pressure (Colin Prodigy II, Colin Medical Instruments, San Antonio, TX). Signals were integrated with Biopac MP100 hardware. Electrocardiograph and impedance cardiograph signals were scored off-line by trained personnel. Signals were visually examined and the ensembled averages were analyzed using Mindware software (Mindware Technologies, Gahanna, OH). Reactivity scores were computed by subtracting scores taken during the final minute of baseline (the “most relaxed” portion) from those collected during the first minute of the speech (the “most reactive” portion). We focused on two measures that provide the best distinction between challenge and threat states: cardiac output (CO) and total peripheral resistance (TPR). CO is the amount of blood ejected from the heart during one minute and is calculated by first estimating stroke volume (the amount of blood ejected during each beat) and multiplying that by heart rate. Increases in CO index improved cardiac efficiency. TPR is a measure of overall vasoconstriction/vasodilation. During threat states, the peripheral vasculature constricts so as to limit blood flow to the periphery. TPR was calculated with the following formula: (mean arterial pressure / CO) × 80 (Sherwood, Allen, Fahrenberg, Kelsey, Lovallo, & van Dooren et al., 1990 (link)).
Publication 2011
BLOOD Blood Circulation Blood Pressure Cardiac Output Cardiography, Impedance Electrocardiography Heart Prodigy Rate, Heart Speech Stroke Volume Total Peripheral Resistance Vasoconstriction Vasodilation

Most recents protocols related to «Cardiography, Impedance»

We performed impedance-cardiography and cuff-based BP measurement at rest and under mental and physical load in 71 young and healthy adults. After welcoming subjects and receiving their written consent, we proceeded with the experiment. We asked the participants to sit on a chair behind a desk with all devices attached. After 2 min at total rest, we initiated the impedance cardiography and performed the first BP measurement. This measurement was taken to record at rest (baseline) measurements of BP and impedance cardiography results which we needed to show intraindividual changes in the following analysis. Subsequently, the subjects each went through two experimental phases (Figure 2).
Full text: Click here
Publication 2023
Adult Cardiography, Impedance Medical Devices Physical Examination
We used the CardioScreen® 1000 (medis Medizinische Messtechnik GmbH, Ilmenau, Germany) device to perform impedance cardiography. The device has been validated (as bedside monitor, named niccomo™-monitor) (16 (link), 23 (link)–25 (link)). We recorded all parameters provided by the device, including the PEP, heart rate, left ventricular ejection time, and Heather index. The Heather index is calculated as a combination of acceleration and velocity of blood flow (both as index values, relative to body surface area) and is a parameter of impedance cardiography said to represent contractility and overall sympathetic tone (26 (link)). For BP measurement, we used the validated cuff-based OnTrak 90227 device (Spacelabs® Healthcare) (27 (link)). For ensuring valid cuff-based measurement, we recorded the cuff’s pressure curves via a Y-connection, and recorded data via a SOMNOtouch™ NIBP (SOMNOmedics GmbH).
The devices were time synchronized in a two-step process. The CardioScreen® and SOMNOtouch™ devices were both initiated to within second precision during device setup. As both devices recorded an ECG, we were then able to synchronize the signals with millisecond precision.
We used a Ergometrics 900 L (ergoline GmbH, Bitz, Germany) recumbent bike ergometer with 60° inclination to enable controllable physical load while minimizing upper body movement. This is of utmost importance for the 8-lead cardio impedance device and during cuff-based BP measurement. The experimental setup, combined with quality assessment of cuff pressure curves, allowed us to maximize the quality of measurements included in the final analysis. We time synchronized all devices.
Full text: Click here
Publication 2023
Acceleration Blood Flow Velocity Body Surface Area Cardiography, Impedance Ergoline Left Ventricles Medical Devices Movement Muscle Contraction Physical Examination Pressure Rate, Heart
We performed a quality check for all impedance cardiography datasets, excluding measurement errors defined as abnormal changes in heart rate (change > 30% in less than 3 s). In line with manufacturer recommendations, we averaged the beat-to-beat data over four heartbeats.
Blood pressure measurements were assessed for undisturbed pressure curves. We excluded measurements when there was an increase of cuff pressure of more than 8 mmHg during cuff deflation.
To decide whether to use the ECG’s Q-wave (physiological beginning of PEP = start of ventricular depolarization) or the R-wave (easier detection), we compared the PEP derived from both starting points using a correlation analysis and analyzed the changes in the Q-R-time and its dependency to mental or physical load.
We analyzed changes of PEP during the TSST and ergometer load separately by modeling a mixed linear model (IBM SPSS Statistics 27). For Regression analyses, we performed linear regression and non-linear, R2-calculation via Scikit-learn (30 ). To find differences in PEP’s behavior under different circumstances, we calculated a mixed linear model and adjusted for the heart rate as a covariate factor. Subsequently, we trained a k-nearest-neighbor classifier with patient mean values for rest, TSST and bike ergometer load. In accordance with best practices of Machine Learning we performed a strict separation of training and test data. We tested the classifier using a subject-dependent train-test split. This means that all three data-points of any given patient had to be either in the train or the test group, therefore reducing the change for data-leakage. We retrieved our results by evaluating the classifier in an 80/20 k-fold (equates to fivefold) evaluation scheme. We averaged the results (positive predictive value/sensitivity) over all three outcomes (rest, mental load, physical load) and over all k-fold iterations to provide an aggregate estimation of the classifiers performance.
To illustrate patient specific differences at rest and under mental and physical load, we visualized data at rest measurement, first TSST question and last ergometer step (maximum load) in a boxplot. We analyzed the differences via a one-way ANOVA. The statistical analysis was performed in close collaboration with Charité’s Institute of Biometry and Clinical Epidemiology. We used the conservative Bonferroni correction for all multi-group comparisons.
To estimate the effect of neglecting or estimating the PEP, we analyzed a previously published and often-cited relation between PWV and BP (6 (link)). We applied the relation for a standard human (1.80 m) and translated the relation to a pulse-arrival-time (PAT, time from ECG Q-wave to arrival of the pulse wave in the periphery) vs. BP relation. Thereafter, we used our data to estimate the PEP’s proportion of the PAT for different BP levels (regression) and subtracted the PEP to receive the pulse-transit-time (PTT = PAT–PEP). We then analyzed the PEP estimation uncertainty (intra- and interindividual PEP variability at similar BP levels) and calculated confidence intervals for one SD (67% of values) and two SDs (95% of values) for PTT. Applying this relation, we were able to determine the BP measurement estimation uncertainty caused by either neglecting or estimating the PEP for PWV based BP measurement.
Full text: Click here
Publication 2023
Cardiography, Impedance Determination, Blood Pressure Heart Ventricle Homo sapiens Hypersensitivity neuro-oncological ventral antigen 2, human Patients Physical Examination physiology Pressure Pulse Rate Rate, Heart
Noninvasive thoracic impedance cardiography (ICG) was recorded via standard tetrapolar spot electrode placement along the spine of each subject. One electrode was placed at the top of the neck, and a second electrode was placed roughly at the seventh vertebra of the cervical spine (approximately 5 cm from the first electrode). A distance of 25–35 cm (depending on subject height) was between the second and third electrodes from the uppermost electrode. The Biopac EBI100C system amplified the signals. Delta Z was derived using Acqknowledge 4.4. The software extracted the dZ/dt waveform, providing the following: C-point location using adaptive template matching, X-point location using the minimum dZ/dt 150–275 ms after the C-point, and B-point location using the minimum derivative in the C-QRS interval. Two independent scorers visually detected the B point. Each dZ/dt waveform was visually inspected twice by two researchers for accuracy and manually edited where necessary. Subjects’ height, weight, and distance between second and third electrodes were entered into the analysis routine. The Kubicek/Rho method for stroke volume calculation was selected.
Full text: Click here
Publication 2023
Acclimatization Cardiography, Impedance Cervical Vertebrae MS 27-275 Neck Stroke Volume Vertebra Vertebral Column

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Cardiography, Impedance Heart Ventricle lantibiotic Pep5 Stimulations, Electric Valves, Aortic

Top products related to «Cardiography, Impedance»

The TruOne® 2400 is a laboratory equipment product designed for analysis and testing purposes. It serves as a core function for various applications within the scientific and research domains.
The NICO100C is a biomedical device that measures non-invasive cardiac output. It provides hemodynamic information by analyzing the impedance changes in the thorax during the cardiac cycle.
Sourced in Germany
GE-Cardiosoft is a software platform developed by GE Healthcare for the acquisition, analysis, and management of cardiac data. It serves as a comprehensive solution for performing electrocardiograms (ECGs) and other cardiac tests in a clinical setting.
The MP150 Data Acquisition Unit is a versatile hardware device designed for recording and analyzing a wide range of physiological signals. It offers high-resolution data acquisition capabilities, enabling users to capture and digitize various biological signals with precision. The MP150 serves as the core component of the BIOPAC data acquisition system, providing a reliable platform for collecting and managing physiological data.
Sourced in Switzerland, France
The Arduino Uno R3 is an open-source microcontroller board based on the Microchip ATmega328P microcontroller. It has 14 digital input/output pins, 6 analog inputs, a 16 MHz quartz crystal, a USB connection, a power jack, an ICSP header, and a reset button. It provides the core functionality for various electronic projects and prototypes.
The ECG amplifier is a laboratory equipment device designed to measure and amplify electrical signals generated by the heart during cardiac activity. It is a core component in the study and analysis of electrocardiography (ECG) data. The device amplifies the weak electrical signals from the heart and converts them into a format suitable for further processing and analysis.
Sourced in United States
The Alice 5 System is a comprehensive sleep diagnostic device designed for the evaluation of sleep disorders. It offers a multi-parameter recording capability, allowing for the simultaneous monitoring of various physiological signals to assist healthcare professionals in the assessment and management of sleep-related conditions.
Sourced in United States, United Kingdom
The MAC 5000 is a diagnostic electrocardiograph (ECG) device manufactured by GE Healthcare. It is designed to record and analyze the electrical activity of the heart. The device provides accurate and reliable data to assist healthcare professionals in the diagnosis and management of cardiac conditions.
Sourced in United Kingdom
The Dinamap Carescape V100 monitor is a compact and portable device designed for patient vital signs monitoring. It measures and displays key physiological parameters such as blood pressure, pulse rate, and temperature. The monitor is intended for use in various healthcare settings to provide clinicians with real-time patient data.
Sourced in United States, United Kingdom
The MAC 5500 is a 12-lead electrocardiograph (ECG) device manufactured by GE Healthcare. It is designed to acquire, display, and store high-quality electrocardiograms. The device features an intuitive user interface and advanced signal processing capabilities to provide reliable cardiac data for clinical evaluation.

More about "Cardiography, Impedance"

Impedance Cardiography: Unveiling Cardiac Hemodynamics Non-Invasively

Impedance cardiography (ICG), also known as thoracic electrical bioimpedance (TEB) or transthoracic electrical bioimpedance (TEB), is a non-invasive technique used to measure changes in electrical impedance within the thoracic cavity.
This method provides valuable insights into cardiac function and hemodynamics by applying a small, high-frequency alternating current to the body and measuring the resulting voltage changes, which are influenced by factors such as blood flow, fluid content, and tissue composition.
ICG has been utilized in a variety of clinical and research settings, including the assessment of cardiac output, fluid status, and cardiovascular reactivity.
The technique has been employed with devices like the TruOne® 2400, NICO100C, GE-Cardiosoft, MP150 Data Acquisition Unit, and Arduino Uno R3 board, as well as ECG amplifiers and systems like the Alice 5 System, MAC 5000, Dinamap Carescape V100 monitor, and MAC 5500.
By leveraging the insights gained from ICG, researchers and clinicians can optimize their investigations and improve patient outcomes.
The PubCompare.ai platform can streamline the process by providing easy access to relevant protocols from the literature, preprints, and patents, and offering AI-powered comparisons to identify the best approaches and products for your specific needs.
This can help enhance the efficiency and outcomes of your scientific inquiries focused on cardiac function and hemodynamics.
OtherTerms: Thoracic electrical bioimpedance, transthoracic electrical bioimpedance, cardiac output, fluid status, cardiovascular reactivity, TruOne® 2400, NICO100C, GE-Cardiosoft, MP150 Data Acquisition Unit, Arduino Uno R3, ECG amplifier, Alice 5 System, MAC 5000, Dinamap Carescape V100, MAC 5500